blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1433478

EP1433478 - Pharmaceutical formulae for thyroid hormones and procedures for obtaining them [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.09.2010
Database last updated on 14.11.2024
Most recent event   Tooltip08.07.2011Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 10.08.2011  [2011/32]
Applicant(s)For all designated states
ALTERGON S.A.
Via Dogana Vecchia, 2
CH-6900 Lugano / CH
[2004/27]
Inventor(s)01 / Di Martino, Alessandro
Via Liberta 67
21030 Casalzuigno / IT
02 / Mateo, Angel
Residenza Cantone - Milano 2
20090 Segrate / IT
03 / Garavani, Alberto
Via Bollini 2
6946 Ponte Capriasca / CH
04 / Marchiorri, Maurizio
Via Don Orsenigo 11
22039 Valbrona / IT
 [2004/27]
Representative(s)Gervasi, Gemma
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2009/40]Gervasi, Gemma
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9
20122 Milano / IT
Former [2004/27]Gervasi, Gemma, Dr.
Notarbartolo & Gervasi S.p.A., Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date03029729.523.12.2003
[2004/27]
Priority number, dateIT2002MI0277727.12.2002         Original published format: IT MI20022777
[2004/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1433478
Date:30.06.2004
Language:EN
[2004/27]
Type: B1 Patent specification 
No.:EP1433478
Date:11.11.2009
Language:EN
[2009/46]
Search report(s)(Supplementary) European search report - dispatched on:EP30.03.2004
ClassificationIPC:A61K9/00, A61K9/48
[2004/27]
CPC:
A61K9/2095 (EP,US); A61K9/2063 (EP,US); A61P5/14 (EP);
A61K9/4866 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/27]
TitleGerman:Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren[2004/27]
English:Pharmaceutical formulae for thyroid hormones and procedures for obtaining them[2004/27]
French:Formes de dosage contenant des hormones thyroidiennes et procédé de préparation de ces formes[2004/27]
Examination procedure13.12.2004Examination requested  [2005/06]
15.05.2007Despatch of a communication from the examining division (Time limit: M06)
28.09.2007Reply to a communication from the examining division
02.06.2009Communication of intention to grant the patent
11.09.2009Fee for grant paid
11.09.2009Fee for publishing/printing paid
Opposition(s)12.08.2010No opposition filed within time limit [2010/42]
Fees paidRenewal fee
13.12.2005Renewal fee patent year 03
30.11.2006Renewal fee patent year 04
23.11.2007Renewal fee patent year 05
20.11.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY11.11.2009
EE11.11.2009
FI11.11.2009
RO11.11.2009
BG11.02.2010
PT11.03.2010
[2011/32]
Former [2011/14]CY11.11.2009
EE11.11.2009
FI11.11.2009
RO11.11.2009
IT23.12.2009
BG11.02.2010
PT11.03.2010
Former [2010/35]CY11.11.2009
EE11.11.2009
FI11.11.2009
RO11.11.2009
BG11.02.2010
PT11.03.2010
Former [2010/25]CY11.11.2009
FI11.11.2009
PT11.03.2010
Former [2010/22]FI11.11.2009
PT11.03.2010
Documents cited:Search[A]GB1180574  (ISRAEL MURRAY [US]) [A] 1-24 * claim - *;
 [A]WO02089917  (KAROBIO AB [SE], et al) [A] 1-24* claim - *;
 [PX]EP1291021  (ALTERGON SA [CH]) [PX] 1-24 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.